BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28459415)

  • 41. Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX(®) in Portugal.
    Marques A; Lourenço Ó; Ortsäter G; Borgström F; Kanis JA; da Silva JA
    Calcif Tissue Int; 2016 Aug; 99(2):131-41. PubMed ID: 27016370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of hip fracture in Romania and the development of a Romanian FRAX model.
    Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
    Calcif Tissue Int; 2013 May; 92(5):429-36. PubMed ID: 23334302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of the 10-year risk of fracture in Italian postmenopausal women using FRAX®: a north Italian multicenter study.
    Pedrazzoni M; Girasole G; Giusti A; Barone A; Pioli G; Passeri G; Palummeri E; Bianchi G
    J Endocrinol Invest; 2011 Dec; 34(11):e386-91. PubMed ID: 21750394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of hip fracture and the development of FRAX in Ukraine.
    Povoroznyuk VV; Grygorieva NV; Kanis JA; Ev M; Johansson H; Harvey NC; Korzh MO; Strafun SS; Vaida VM; Klymovytsky FV; Vlasenko RO; Forosenko VS
    Arch Osteoporos; 2017 Dec; 12(1):53. PubMed ID: 28567714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A FRAX model for the estimation of osteoporotic fracture probability in Portugal.
    Marques A; Mota A; Canhão H; Romeu JC; Machado P; Ruano A; Barbosa AP; Dias AA; Silva D; Araújo D; Simões E; Aguas F; Rosendo I; Silva I; Crespo J; Alves JD; Costa L; Mascarenhas M; Lourenço Ó; Ferreira PL; Lucas R; Roque R; Branco JC; Tavares V; Johansson H; Kanis J; Pereira da Silva JA
    Acta Reumatol Port; 2013; 38(2):104-12. PubMed ID: 24141347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spine-hip T-score difference predicts major osteoporotic fracture risk independent of FRAX(®): a population-based report from CAMOS.
    Leslie WD; Kovacs CS; Olszynski WP; Towheed T; Kaiser SM; Prior JC; Josse RG; Jamal SA; Kreiger N; Goltzman D;
    J Clin Densitom; 2011; 14(3):286-93. PubMed ID: 21723768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fracture risk prediction in outpatients from Krakow Region using FRAX tool versus fracture risk in 11-year follow-up.
    Czerwiński E; Borowy P; Kumorek A; Amarowicz J; Górkiewicz M; Milert A
    Ortop Traumatol Rehabil; 2013; 15(6):617-28. PubMed ID: 24662908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
    Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
    Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Race/Ethnicity on United States FRAX Calculations and Treatment Qualification: A Registry-Based Study.
    Leslie WD;
    J Bone Miner Res; 2023 Dec; 38(12):1742-1748. PubMed ID: 37548387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of FRAX without BMD: an age-related analysis of the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V-1, 2010).
    Kim JW; Koh JM; Park JH; Chang JS
    Bone; 2015 Jun; 75():27-31. PubMed ID: 25697083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FRAX and the assessment of fracture probability in men and women from the UK.
    Kanis JA; Johnell O; Oden A; Johansson H; McCloskey E
    Osteoporos Int; 2008 Apr; 19(4):385-97. PubMed ID: 18292978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Updated fracture incidence rates for the US version of FRAX.
    Ettinger B; Black DM; Dawson-Hughes B; Pressman AR; Melton LJ
    Osteoporos Int; 2010 Jan; 21(1):25-33. PubMed ID: 19705048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.
    McCloskey EV; Johansson H; Oden A; Austin M; Siris E; Wang A; Lewiecki EM; Lorenc R; Libanati C; Kanis JA
    J Bone Miner Res; 2012 Jul; 27(7):1480-6. PubMed ID: 22431426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models.
    Ramanau H; Chernyanin I; Rudenka E; Lesnyak O; Zakroyeva A; Bilezikian JP; Johansson H; Harvey NC; McCloskey EV; Kanis JA
    Arch Osteoporos; 2018 Apr; 13(1):42. PubMed ID: 29666948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm.
    Klop C; Welsing PM; Leufkens HG; Elders PJ; Overbeek JA; van den Bergh JP; Bijlsma JW; de Vries F
    PLoS One; 2015; 10(12):e0143800. PubMed ID: 26633011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?
    Sornay-Rendu E; Munoz F; Delmas PD; Chapurlat RD
    J Bone Miner Res; 2010 Oct; 25(10):2101-7. PubMed ID: 20499352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The characteristics of osteoporotic fractures in the region of Bialystok (BOS-2). The application of the WHO algorithm, FRAX®BMI and FRAX®BMD assessment tools to determine patients for intervention.
    Badurski J; Jeziernicka E; Dobreńko A; Nowak N; Daniluk S; Rybaczuk M; Wiśniowiecka M
    Endokrynol Pol; 2011; 62(4):290-8. PubMed ID: 21879467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing self-perceived and estimated fracture risk by FRAX® of women with osteoporosis.
    Baji P; Gulácsi L; Horváth C; Brodszky V; Rencz F; Péntek M
    Arch Osteoporos; 2017 Dec; 12(1):4. PubMed ID: 28004298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FRAX underestimates fracture risk in patients with diabetes.
    Giangregorio LM; Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    J Bone Miner Res; 2012 Feb; 27(2):301-8. PubMed ID: 22052532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.